Study Title: A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined with Either Trastuzumab and Hyaluronidase-oysk (HERCEPTIN HYLECTA) or Pertuzumab Trastuzumab and Hyaluronidase-zzfx (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Orr, Brian, at orrb@musc.edu.Study Coordinator, Knox, Crystal, at knoxc@musc.edu.Trial opened at the following institutions: Medical University of South Carolina